Clinical trial

Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data

NCT07599293

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2024-10-13

PhaseN/A

Study timeline

Study start (actual)2024-10-13Date precision: day

Registry last updated2026-07-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Preserved Ejection Fractionunresolved

Chronic Heart Failureunresolved

Type 2 Diabetes Mellitusunresolved

Interventions

EmpagliflozinDRUG · verified · RxNorm: empagliflozin

SitagliptinDRUG · verified · RxNorm: sitagliptin

Sponsors & collaborators

Brigham and Women's Hospitallead sponsor

Food and Drug Administration (FDA)collaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07599293 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.